You are here

  • Home
  • Archive
  • Volume 4, Issue 1
  • Dipeptidyl peptidase-4 inhibition by Saxagliptin prevents inflammation and renal injury by targeting the Nlrp3/ASC inflammasome

Article info

Article menu

Download PDFPDF

Pharmacology and Therapeutics
Dipeptidyl peptidase-4 inhibition by Saxagliptin prevents inflammation and renal injury by targeting the Nlrp3/ASC inflammasome

Authors

  • Yochai Birnbaum Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, Texas, USA Section of Cardiology, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA PubMed articlesGoogle scholar articles
  • Mandeep Bajaj Section of Endocrinology, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA PubMed articlesGoogle scholar articles
  • Jinqiao Qian Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, Texas, USA Department of Anesthesiology, First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China PubMed articlesGoogle scholar articles
  • Yumei Ye Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, Texas, USA PubMed articlesGoogle scholar articles
  1. Correspondence to Professor Yumei Ye; yumye{at}utmb.edu
View Full Text

Citation

Birnbaum Y, Bajaj M, Qian J, et al
Dipeptidyl peptidase-4 inhibition by Saxagliptin prevents inflammation and renal injury by targeting the Nlrp3/ASC inflammasome
BMJ Open Diabetes Research and Care 2016;4:e000227. doi: 10.1136/bmjdrc-2016-000227

Publication history

  • Received March 16, 2016
  • Revised June 21, 2016
  • Accepted June 27, 2016
  • First published August 4, 2016.
Online issue publication 
January 03, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/